APOPTOSIS IN ANTIBODY-DEPENDENT MONOCYTE-MEDIATED CYTOTOXICITY WITH MONOCLONAL-ANTIBODY 17-1A AGAINST HUMAN COLORECTAL-CARCINOMA CELLS - ENHANCEMENT WITH INTERFERON-GAMMA
K. Takamuku et al., APOPTOSIS IN ANTIBODY-DEPENDENT MONOCYTE-MEDIATED CYTOTOXICITY WITH MONOCLONAL-ANTIBODY 17-1A AGAINST HUMAN COLORECTAL-CARCINOMA CELLS - ENHANCEMENT WITH INTERFERON-GAMMA, Cancer immunology and immunotherapy, 43(4), 1996, pp. 220-225
Antibody-dependent cell-mediated cytotoxicity (ADCC) has been consider
ed to be one of the main effector mechanisms by which unconjugated mon
oclonal antibody (mAb) 17-1A can exert an antitumor effect in vivo. Si
nce the apoptotic pathway as well as the necrotic pathway have been sh
own to be utilized in various cytotoxic effector mechanisms, we invest
igated the role of apoptosis in ADCC mediated by monocytes (ADMC) usin
g mAb 17-1A as an antibody and the human colorectal carcinoma cell lin
e, COLO205, as target cells in vitro. The implications of the apoptosi
s during ADMC was demonstrated by means of both a DNA fragmentation as
say and a TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay. Fu
rthermore, interferon gamma (IFN gamma) was also found to enhance the
induction of apoptosis significantly. The addition of superoxide dismu
tase did not reduce the level of the apoptosis, although superoxide an
ion (O-2-) was observed to be produced. However, the release of tumor
necrosis factor alpha (TNF alpha) was significantly enhanced during AD
MC, while, in addition, apoptosis was significantly inhibited by the a
ddition of anti-TNF alpha antibody. These findings indicated that apop
tosis might be implicated in ADMC with mAb 17-1A, which was augmented
by IFN gamma, while, in addition, TNF alpha may also be one of the maj
or mediators of apoptosis.